Navigation Links
24x7 Infection Control, Inc. Announces World's First, Modern “Shield” Against Microbial Contamination

Microbial contamination is the third leading cause of mortality in the U.S., according to the Centers for Disease Control (CDC).

Charleston, SC (PRWEB) March 5, 2010 -- Today’s hospitals have an increasingly dangerous and costly problem. The culprit…Hospital Acquired Infections (HAIs) and they have generated much attention over the last decade. Studies have shown that up to 70% of HAIs are preventable with proper infection control, according to a Nurse Liaison for 24x7 Infection Control, Inc.    

A totally new (to the public) antimicrobial line named Goldshield®™ is a revolutionary product that, through independent studies it was demonstrated to eradicate germs on contact and inhibit their growth. Invented and patented by Emory University, Goldshield®™ is a system of products which includes an antimicrobial that is the first, and only, water-stabilized, non-toxic, non-leaching, environmentally benign solution providing a durable shield against microbial contamination, including mold, mildew and fungi.

Goldshield®™ offers an EPA-registered solution to combat dangerous microbial contamination in virtually every setting including hospitals, outpatient clinics, physicians offices, assisted living facilities, skilled nursing facilities, schools, colleges, athletic clubs, gymnasiums, spas, police departments, emergency medical services, fire departments, correctional institutions, the hospitality industry and commercial laundry facilities, to name a few.

Independent studies conducted at hospitals and universities have demonstrated that Goldshield® is a broad-spectrum bactericide, algaecide and fungicide. In these studies, it has been proven effective against Staphylococcus aureus (Staph), Methicillin-resistant Staphylococcus aureus (MRSA); including HA-MRSA (Healthcare-associated MRSA) and CA-MRSA (community- associated MRSA), Salmonella, E.coli, VRE (Vancomycin-Resistant Enterococci, and other hardy Gram (+) and Gram (-) bacteria. In a recent study in accordance with ASTM (American Society for Testing and Materials) protocols for virucidal efficacy on inanimate surfaces, Goldshield®™ was proven effective against Influenza A as a surrogate for H1N1.

Sharon Harper, an OR nurse and retired, Navy Infection Control Officer, stated, “I have seen the results and can appreciate why Goldshield®™ is so unique. In my opinion, the most exciting use of this new antimicrobial is via a “Bio-Vapor” Steam Cleaning System. This method allows Goldshield®™ to adhere in every ‘nook and cranny’! My mission as the nurse liaison for 24x7 Infection Control, Inc. is to inform government agencies, schools, hospitals, assisted living and long-term care communities that Goldshield®™ is now available.”

The parent company, AP Goldshield LLC is located in the United States, Israel, Asia, and Europe. 24x7 Infection Control, Inc. is an Authorized Distributor for Goldshield®™.

To find out more, please visit

Sharon Harper RN, MSN                                         
Sharon (at) 24x7infectioncontrol (dot) com


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
3. Computers help chemists fight emerging infections
4. Infection contributes to the high rates of oropharyngeal cancers
5. Jefferson immunology researchers halt lethal rabies infection in brain
6. SIV infection of natural hosts provides new insights into HIV disease complexity
7. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
8. Natural aorta grafts have few side effects for infection-prone patients
9. Common misdiagnosis: most women believe they have a yeast infection when they dont
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Post Your Comments:
Related Image:
24x7 Infection Control, Inc. Announces World's First, Modern “Shield” Against Microbial Contamination 
(Date:11/29/2015)... , ... November 29, 2015 , ... Effective immediately, every ... In addition starting on Black Friday Target is offering a “Buy One Scrub Set, ... is a rare opportunity to purchase IguanaMed at a discounted price. , ...
(Date:11/28/2015)... ... 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. EST, ... savings of up to 20% off orders $80 or more to free gifts with purchases, ... hours. , As a competitive e-commerce website for skin care and cosmetic needs, customers will ...
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, while ... light of the recent terrorist attacks in Paris, other cities are taking extra precautions ... reaching U.S. soil. Especially around special events that may be high-profile in nature, the ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced today ... Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics SL ... users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ongoing ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
Breaking Medicine Technology: